Aileron Therapeutics Inc (RNTX) USD0.001

Sell:$1.48Buy:$1.56$0.08 (5.48%)

Prices delayed by at least 15 minutes
Sell:$1.48
Buy:$1.56
Change:$0.08 (5.48%)
Prices delayed by at least 15 minutes
Sell:$1.48
Buy:$1.56
Change:$0.08 (5.48%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
14 November 2025
VOSS CAPITAL LLC10% Owner
Buy
Regular purchase transaction
104,183$1.22$127,592.92926,441
28 October 2025
VOSS CAPITAL LLC10% Owner
Buy
Regular purchase transaction
178,392$1.39$247,964.88500,000
27 October 2025
VOSS CAPITAL LLC10% Owner
Buy
Regular purchase transaction
92,642$1.37$126,919.54822,258
27 October 2025
VOSS CAPITAL LLC10% Owner
Buy
Regular purchase transaction
4,840$1.37$6,624.51321,608
24 October 2025
VOSS CAPITAL LLC10% Owner
Buy
Regular purchase transaction
30,176$1.39$41,956.71729,616
5 December 2024
James Brian WindsorPresident/CEO
Buy
Regular purchase transaction
239$2.24$535.36239
5 December 2024
James Brian WindsorPresident/CEO
Buy
Regular purchase transaction
161$2.25$362.25161

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
28 October 2025
VOSS CAPITAL LLC10% Owner
Buy
Regular purchase transaction
178,392$1.39$247,964.88500,000
14 November 2025
VOSS CAPITAL LLC10% Owner
Buy
Regular purchase transaction
104,183$1.22$127,592.92926,441
27 October 2025
VOSS CAPITAL LLC10% Owner
Buy
Regular purchase transaction
92,642$1.37$126,919.54822,258
24 October 2025
VOSS CAPITAL LLC10% Owner
Buy
Regular purchase transaction
30,176$1.39$41,956.71729,616
27 October 2025
VOSS CAPITAL LLC10% Owner
Buy
Regular purchase transaction
4,840$1.37$6,624.51321,608

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.